In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20.
The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was this industry that developed messenger ribonucleic acid (mRNA) vaccines that put an end to the pandemic. However, biotechnology does not only target viruses in its drug development efforts. While mRNA might have been popularized due to the coronavirus pandemic, the technology which programs the human body to produce certain proteins was initially developed as a cancer treatment.
As a whole, the biotechnology sector relies heavily on technology for progress. This has enabled it to leverage modern-day advances in computing to suit its purposes and drug development. For instance, artificial intelligence, which has recently caught the public’s eye due to the success of the chatbot ChatGPT, was already being used by drugmakers to sift through vast amounts of data and generate insights such as those that characterize the differences between healthy and cancerous cells. This is part of efforts to reduce the massive costs of drug development which often stand in billions of dollars and require drugmakers to run trial-and-error experiments as part of the drug discovery process.
In this piece, we will take a look at the 12 best biotechnology stocks to buy under $20. For more stocks, head on over to 5 Best Biotech Stocks To Buy Under $20.
The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was this industry that developed messenger ribonucleic acid (mRNA) vaccines that put an end to the pandemic. However, biotechnology does not only target viruses in its drug development efforts. While mRNA might have been popularized due to the coronavirus pandemic, the technology which programs the human body to produce certain proteins was initially developed as a cancer treatment.
As a whole, the biotechnology sector relies heavily on technology for progress. This has enabled it to leverage modern-day advances in computing to suit its purposes and drug development. For instance, artificial intelligence, which has recently caught the public’s eye due to the success of the chatbot ChatGPT, was already being used by drugmakers to sift through vast amounts of data and generate insights such as those that characterize the differences between healthy and cancerous cells. This is part of efforts to reduce the massive costs of drug development which often stand in billions of dollars and require drugmakers to run trial-and-error experiments as part of the drug discovery process.
At the same time, the proliferation of the internet of things (IoT) gadgets such as smartwatches have also provided biotechnology companies with novel means of collecting data for clinical trials. For instance, Invitae Corporation partnered up with Apple Inc. in 2019 to use the data from the latter’s Apple Watch as part of researching the genetic causes of cardiovascular disease. Additionally, if you thought that biotechnology was limited to Earthly use, you’d be wrong. The National Aeronautics and Space Administration (NASA) is testing chips that are imbued with human tissue in space.
Simply called Tissue Chips, these contain muscle bundles of cells from people younger than 40 years or older than 60 years to simulate muscle wastage. The simple premise behind this experiment is to use microgravity conditions that see muscle age faster than on Earth to speed up the changes to the muscle by zapping them with electricity and monitoring the changes. Some of the medical areas that the investigation aims to study are osteoarthritis, the blood-brain barrier, the interaction of the respiratory and immune systems to fight infection, and high levels of protein in the urine.
